{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "21216881", "DateCompleted": {"Year": "2011", "Month": "07", "Day": "11"}, "DateRevised": {"Year": "2024", "Month": "03", "Day": "20"}, "Article": {"Language": ["eng"], "ELocationID": ["10.1164/rccm.201011-1813OC"], "ArticleDate": [{"Year": "2011", "Month": "01", "Day": "07"}], "Journal": {"ISSN": "1535-4970", "JournalIssue": {"Volume": "183", "Issue": "9", "PubDate": {"Year": "2011", "Month": "May", "Day": "01"}}, "Title": "American journal of respiratory and critical care medicine", "ISOAbbreviation": "Am J Respir Crit Care Med"}, "ArticleTitle": "Lung function and inflammatory responses in healthy young adults exposed to 0.06 ppm ozone for 6.6 hours.", "Pagination": {"StartPage": "1215", "EndPage": "1221", "MedlinePgn": "1215-21"}, "Abstract": {"AbstractText": ["Exposure to ozone causes a decrease in spirometric lung function and an increase in airway inflammation in healthy young adults at concentrations as low as 0.08 ppm, close to the National Ambient Air Quality Standard for ground level ozone.", "To test whether airway effects occur below the current ozone standard and if they are more pronounced in potentially susceptible individuals, such as those deficient in the antioxidant gene glutathione S-transferase mu 1 (GSTM1).", "Pulmonary function and subjective symptoms were measured in 59 healthy young adults (19-35 yr) immediately before and after exposure to 0.0 (clean air, CA) and 0.06 ppm ozone for 6.6 hours in a chamber while undergoing intermittent moderate exercise. The polymorphonuclear neutrophil (PMN) influx was measured in 24 subjects 16 to 18 hours postexposure.", "Subjects experienced a significantly greater (P = 0.008) change in FEV(1) (\u00b1 SE) immediately after exposure to 0.06 ppm ozone compared with CA (-1.71 \u00b1 0.50% vs. -0.002 \u00b1 0.46%). The decrement in FVC was also greater (P = 0.02) after ozone versus CA (-2.32 \u00b1 0.41% vs. -1.13 \u00b1 0.34%). Similarly, changes in %PMN were greater after ozone (54.0 \u00b1 4.6%) than CA (38.3 \u00b1 3.7%) exposure (P < 0.001). Symptom scores were not different between ozone versus CA. There were no significant differences in changes in FEV(1), FVC, and %PMN between subjects with GSTM1-positive and GSTM1-null genotypes.", "Exposure of healthy young adults to 0.06 ppm ozone for 6.6 hours causes a significant decrement of FEV(1) and an increase in neutrophilic inflammation in the airways. GSTM1 genotype alone appears to have no significant role in modifying the effects."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Environmental Public Health Division (MD-58B), National Health and Environmental Effects Research Laboratory, U.S. Environmental Protection Agency, Research Triangle Park, NC 27711, USA. kim.chong@epa.gov"}], "Identifier": [], "LastName": "Kim", "ForeName": "Chong S", "Initials": "CS"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Alexis", "ForeName": "Neil E", "Initials": "NE"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Rappold", "ForeName": "Ana G", "Initials": "AG"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Kehrl", "ForeName": "Howard", "Initials": "H"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Hazucha", "ForeName": "Milan J", "Initials": "MJ"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Lay", "ForeName": "John C", "Initials": "JC"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Schmitt", "ForeName": "Mike T", "Initials": "MT"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Case", "ForeName": "Martin", "Initials": "M"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Devlin", "ForeName": "Robert B", "Initials": "RB"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Peden", "ForeName": "David B", "Initials": "DB"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Diaz-Sanchez", "ForeName": "David", "Initials": "D"}], "GrantList": [{"GrantID": "P30 ES010126", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "RC1 ES018417-02", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "RC1ES018417", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "RC1 ES018417", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "R01 ES012706", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "R01 ES012706-05", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "R01ES012706", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, N.I.H., Extramural", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Am J Respir Crit Care Med", "NlmUniqueID": "9421642", "ISSNLinking": "1073-449X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Air Pollutants"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "EC 2.5.1.18", "NameOfSubstance": "Glutathione Transferase"}, {"RegistryNumber": "EC 2.5.1.18", "NameOfSubstance": "glutathione S-transferase M1"}], "CommentsCorrectionsList": [{"RefSource": "Am J Respir Crit Care Med. 2011 Jul 15;184(2):150-1. doi: 10.1164/rccm.201104-0606ED", "PMID": "21765027"}, {"RefSource": "Am J Respir Crit Care Med. 2011 Dec 15;184(12):1421-2. doi: 10.1164/ajrccm.184.12.1421", "PMID": "22174117"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": ["toxicity"], "DescriptorName": "Air Pollutants"}, {"QualifierName": [], "DescriptorName": "Exercise"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["drug effects"], "DescriptorName": "Forced Expiratory Volume"}, {"QualifierName": ["drug effects"], "DescriptorName": "Glutathione Transferase"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["physiopathology"], "DescriptorName": "Inflammation"}, {"QualifierName": [], "DescriptorName": "Inhalation Exposure"}, {"QualifierName": ["drug effects", "physiopathology"], "DescriptorName": "Lung"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["drug effects"], "DescriptorName": "Neutrophils"}, {"QualifierName": ["toxicity"], "DescriptorName": "Ozone"}, {"QualifierName": [], "DescriptorName": "Reference Values"}, {"QualifierName": ["methods"], "DescriptorName": "Respiratory Function Tests"}, {"QualifierName": [], "DescriptorName": "Reverse Transcriptase Polymerase Chain Reaction"}, {"QualifierName": [], "DescriptorName": "Spirometry"}, {"QualifierName": [], "DescriptorName": "Time Factors"}, {"QualifierName": ["drug effects"], "DescriptorName": "Vital Capacity"}, {"QualifierName": [], "DescriptorName": "Young Adult"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Silverman F, Folinsbee LJ, Barnard JW, Shephard RJ. Pulmonary function changes in ozone: interaction of concentration and ventilation. J Appl Physiol 1976;41:859\u2013864.", "ArticleIdList": ["1002640"]}, {"Citation": "Hazucha MJ. Relationship between ozone exposure and pulmonary function changes. J Appl Physiol 1987;62:1671\u20131680.", "ArticleIdList": ["3298195"]}, {"Citation": "Folinsbee LJ, McDonnell WF, Horstman DH. Pulmonary function and symptom responses after 6.6-hour exposure to 0.12 ppm ozone with moderate exercise. J Air Pollut Control Assoc 1988;38:28\u201335.", "ArticleIdList": ["3356996"]}, {"Citation": "Horstman DH, Folinsbee LJ, Ives PJ, Abdul-Salaam S, McDonnell WF. Ozone concentration and pulmonary response relationships for 6.6-hour exposure with five hours of moderate exercise to 0.08, 0.10, and 0.12 ppm. Am Rev Respir Dis 1990;142:1158\u20131163.", "ArticleIdList": ["2240838"]}, {"Citation": "McDonnell WF, Kehrl HR, Abdul-Salaam S, Ives PJ, Folinsbee LJ, Devlin RB, O'Neil JJ, Horstman DH. Respiratory response of humans exposed to low levels of ozone for 6.6 hours. Arch Environ Health 1991;46:145\u2013150.", "ArticleIdList": ["2039268"]}, {"Citation": "Adams WC. Comparison of chamber and face mask 6.6-hour exposure to 0.08 ppm ozone via square-wave and triangular profiles on pulmonary responses. Inhal Toxicol 2003;15:265\u2013281.", "ArticleIdList": ["12579457"]}, {"Citation": "Adams WC. Comparison of chamber 6.6-h exposure to 0.04\u20130.08 ppm ozone via square-wave and triangular profiles on pulmonary responses. Inhal Toxicol 2006;18:127\u2013136.", "ArticleIdList": ["16393927"]}, {"Citation": "Koren HS, Devlin RB, Graham DE, Mann R, McGee MP, Horstman DH, Kozumbo WJ, Becker S, House DE, McDonnell WF, et al. Ozone-induced inflammation in the lower airways of human subjects. Am Rev Respir Dis 1989;139:407\u2013415.", "ArticleIdList": ["2913889"]}, {"Citation": "Devlin RB, McDonnell WF, Mann R, Becker S, House DE, Koren HS. Exposure of humans to ambient levels of ozone for 6.6 hours causes cellular and biochemical changes in the lung. Am Rev Respir Dis 1991;4:72\u201381.", "ArticleIdList": ["1846079"]}, {"Citation": "Schelegle ES, Siefkin AD, McDonald RJ. Time course of ozone-induced neutrophilia in normal humans. Am Rev Respir Dis 1991;142:1353\u20131358.", "ArticleIdList": ["2048824"]}, {"Citation": "Devlin RB, McDonnell WF, Becker S, Madden MC, McGee MP, Perez R, Hatch G, House DE, Koren HS. Time-dependent changes of inflammatory mediators in the lungs of humans exposed to 0.4 ppm ozone for 2 hr: a comparison of mediators found in bronchoalveolar lavage fluid 1 and 18 hr after exposure. Toxicol Appl Pharmacol 1996;138:176\u2013185.", "ArticleIdList": ["8658507"]}, {"Citation": "Alexis NE, Lay JC, Hazucha M, Harris B, Hernandez ML, Bromberg PA, Kehrl H, Diaz- Sanchez D, Kim CS, Devlin RB, et al. Low-level ozone exposure induces airways inflammation and modifies cell surface phenotypes in healthy humans. Inhal Toxicol 2010;22:593\u2013600.", "ArticleIdList": ["PMC3162473", "20384440"]}, {"Citation": "Strickland MJ, Darrow LA, Klein M, Flanders WD, Sarnet JA, Walter LA, Sarnet SE, Mulholland JA, Tolbert PE. Short-term association between ambient air pollutants and pediatric asthma emergency department visits. Am J Respir Crit Care Med 2010;182:307\u2013316.", "ArticleIdList": ["PMC2921597", "20378732"]}, {"Citation": "Brown JB, Bateson TF, McDonnell WF. Effects of exposure to 0.06 ppm ozone on FEV1 in humans: a secondary analysis of existing data. Environ Health Perspect 2008;16:1023\u20131026.", "ArticleIdList": ["PMC2516571", "18709151"]}, {"Citation": "Schelegle ES, Morales CA, Walby WF, Marion S, Allen RP. 6.6-hour inhalation of ozone concentration from 60 to 87 parts per million in healthy humans. Am J Respir Crit Care Med 2009;180:265\u2013272.", "ArticleIdList": ["19447899"]}, {"Citation": "McDonnel WF, Horstman DH, Abdul-Salaam S, House DE. Reproducibility of individual responses to ozone exposure. Am Rev Respir Dis 1985;131:36\u201340.", "ArticleIdList": ["3966712"]}, {"Citation": "McDonnel WF, Muller KE, Bromberg PA, Shy CM. Predictors of individual differences in acute response to ozone exposure. Am Rev Respir Dis 1993;147:818\u2013825.", "ArticleIdList": ["8466115"]}, {"Citation": "Romieu I, Sienra-Monge JJ, Ramierez-Aguilar M, Moreno-Macias H, Reyes-Ruiz NI, Estela del Rio-Navarro B, Hernandez-Avila M, London SJ. Genetic polymorphism of GSTM1 and antioxidant supplementation influence lung function in relation to ozone exposure in asthmatic children in Mexico City. Thorax 2004;59:8\u201310.", "ArticleIdList": ["PMC1758856", "14694237"]}, {"Citation": "Gilliland FD, Gauderman WJ, Vora H, Rappaport E, Dubeau L. Effects of glutathione-S- transferase M1, T1, and P1 on childhood lung function growth. Am J Respir Crit Care Med 2002;166:710\u2013716.", "ArticleIdList": ["12204870"]}, {"Citation": "Alexis NE, Zhou H, Lay JC, Harris B, Hernandez ML, Lu TS, Bromberg PA, Diaz-Sanchez D, Devlin RB, Kleeberger SR, et al. The glutathione-S-transferase Mu 1 null genotype modulates ozone-induced airway inflammation in human subjects. J Allergy Clin Immunol 2009;124:1222\u20131228.", "ArticleIdList": ["PMC3038610", "19796798"]}, {"Citation": "Yang IA, Fong KM, Zimmerman PV, Holgate ST, Holloway JW. Genetic susceptibility to the respiratory effects of air pollution. Thorax 2008;63:555\u2013563.", "ArticleIdList": ["18511640"]}, {"Citation": "Kim CS, Kehrl H, Hazucha MJ, Rappold AG, Brown JB, Devlin RB, Diaz-Sanchez D. Pulmonary response in healthy young adults exposed to low concentration of ozone for 6.6 hours with mild exercise. Am J Respir Crit Care Med 2010;181:A1728.", "ArticleIdList": ["PMC3114053", "21216881"]}, {"Citation": "Miller MR, Hankinson J, Brusasco HV, Burgos F, Casaburi R, Coates A, Carpo R, Enright P, van der Grinten CPM, Gustafsson P, et al. Standardization of spirometry. In: Brusco V, Carpo R, Viegi G, editors. ATS/ERS task force: standardization of lung function testing. Eur Respir J 2005;26:319\u2013338.", "ArticleIdList": ["16055882"]}, {"Citation": "Gilliland FD, Li YF, Dubeau L, Berhane K, Avol E, McConnell R, Gauderman WJ, Peters JM. Effects of glutathione S-transferase M1, maternal smoking during pregnancy, and environmental tobacco smoke on asthma and wheezing in children. Am J Respir Crit Care Med 2002;166:457\u2013463.", "ArticleIdList": ["12186820"]}, {"Citation": "Alexis NE, Hu SH, Zeman K, Alter T, Bennett WD. Induced sputum derives from the central airways: confirmation using radiolabelled aerosol bolus delivery technique. Am J Respir Crit Care Med 2001;164:1964\u20131970.", "ArticleIdList": ["11734453"]}, {"Citation": "US Environmental Protection Agency. National Ambient Air Quality Standard for ozone: Final Rule 40 CFR Parts 50 and 58. Fed Regist 2008;73:16436\u201316514."}, {"Citation": "Hazucha MJ, Folinsbee LJ, Bromberg PA. Distribution and reproducibility of spirometric response to ozone by gender and age. J Appl Physiol 2003;95:1917\u20131925.", "ArticleIdList": ["12871968"]}, {"Citation": "Lauritzen SK, Adams WC. Ozone inhalation effects consequent to continuous exercise in females: comparison with males. J Appl Physiol 1985;59:1601\u20131606.", "ArticleIdList": ["4066592"]}, {"Citation": "Chen C, Arjomandi N, Tager IB, Holland N, Balmes JR. Effects of antioxidant enzyme polymorphisms on ozone-induced lung function changes. Eur Respir J 2007;30:677\u2013683.", "ArticleIdList": ["PMC3282174", "17652311"]}, {"Citation": "Taylor-Clark TE, Undem BJ. Ozone activates airway nerves via the selective stimulation of TRPA1 ion channels. J Physiol 2010;588:423\u2013433.", "ArticleIdList": ["PMC2825608", "20008466"]}, {"Citation": "Barnes PJ, Karin M. Nuclear factor-\u03baB \u2013 a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997;336:1066\u20131071.", "ArticleIdList": ["9091804"]}, {"Citation": "Vagaggini B, Taccola M, Conti I, Carnevali S, Cianchetti S, Batoli ML, Bacci E, Dente FL, Franco A, Giannini D, et al. Budesonide reduces neutrophilic but not functional airway response to ozone in mild asthmatics. Am J Respir Crit Care Med 2001;164:2172\u20132176.", "ArticleIdList": ["11751182"]}, {"Citation": "Blomberg A, Mudway IS, Nordenhail C, Hedenstr\u00f6m H, Kelly FJ, Frew AJ, Holgate ST, Sandst\u00f6rm T. Ozone-induced lung function decrements do not correlate with early airway inflammation or antioxidant responses. Eur Respir J 1999;13:1418\u20131428.", "ArticleIdList": ["10445622"]}]}], "History": [{"Year": "2011", "Month": "1", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2011", "Month": "1", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2011", "Month": "7", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2012", "Month": "5", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["21216881", "PMC3114053", "10.1164/rccm.201011-1813OC", "201011-1813OC"]}}], "PubmedBookArticle": []}